His primary areas of study are Colorectal cancer, Internal medicine, Genome, Vertebrate and Cancer research. Colorectal cancer is a subfield of Cancer that he studies. His studies deal with areas such as Endocrinology and Oncology as well as Internal medicine.
His research on Genetics and Gene is centered around Genome. The study incorporates disciplines such as Evolutionary biology, Comparative genomics, Living fossil, Lamprey and Coelacanth in addition to Vertebrate. His research investigates the link between Cancer research and topics such as Molecular biology that cross with problems in Bone morphogenetic protein, In vivo, IC50, Protein arginine methyltransferase 5 and Histone methyltransferase.
His main research concerns Colorectal cancer, Internal medicine, Genome, Cancer research and Genetics. His study on Colorectal cancer also encompasses disciplines like
His Genome research incorporates elements of Evolutionary biology, Vertebrate, Germline and Lamprey. His study looks at the relationship between Cancer research and fields such as Lymphoma, as well as how they intersect with chemical problems. His Tiger salamander research extends to Genetics, which is thematically connected.
Colorectal cancer, Cancer, Evolutionary biology, Internal medicine and Oncology are his primary areas of study. His work carried out in the field of Colorectal cancer brings together such families of science as Neoadjuvant therapy, Cancer research and Chemotherapy. His Cancer research is multidisciplinary, incorporating perspectives in Gynecology, Nomogram and Retrospective cohort study.
The various areas that he examines in his Evolutionary biology study include Vertebrate, Genome, Gene, Genetic variation and Transcriptome. J. Joshua Smith focuses mostly in the field of Genome, narrowing it down to topics relating to Single-nucleotide polymorphism and, in certain cases, Pacific lamprey and Genome evolution. His work on Lynch syndrome, Fecal Immunochemical Test and Asymptomatic as part of general Internal medicine study is frequently connected to Cost effectiveness and University teaching, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
J. Joshua Smith mainly focuses on Cancer, Internal medicine, Colorectal cancer, Oncology and Evolutionary biology. In general Cancer study, his work on Neoadjuvant therapy and Total mesorectal excision often relates to the realm of Staffing, thereby connecting several areas of interest. Many of his research projects under Colorectal cancer are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His Oncology study incorporates themes from Cancer type, Immune checkpoint inhibitors, Cohort and After treatment. His Evolutionary biology research includes themes of Vertebrate, Genome, Gene, Single-nucleotide polymorphism and Local adaptation. His study on Transcriptome is often connected to Vallecula as part of broader study in Gene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne;Philip D. Lambert;Simon Schenk;David P. Carney.
Nomograms in oncology: more than meets the eye
Vinod P Balachandran;Mithat Gonen;J Joshua Smith;Ronald P DeMatteo.
Lancet Oncology (2015)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K Knutson;Tim J Wigle;Natalie M Warholic;Christopher J Sneeringer.
Nature Chemical Biology (2012)
The African coelacanth genome provides insights into tetrapod evolution
Chris T. Amemiya;Chris T. Amemiya;Jessica Alfoldi;Alison P. Lee;Shaohua Fan.
Sequencing of the sea lamprey (Petromyzon marinus) genome provides insights into vertebrate evolution
Jeramiah J. Smith;Shigehiro Kuraku;Carson Holt;Tatjana Sauka-Spengler.
Nature Genetics (2013)
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer
J. Joshua Smith;Natasha G. Deane;Fei Wu;Nipun B. Merchant.
SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes
Takeshi Yoshizaki;Jill C. Milne;Takeshi Imamura;Simon Schenk.
Molecular and Cellular Biology (2009)
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
Sarah K. Knutson;Satoshi Kawano;Yukinori Minoshima;Natalie M. Warholic.
Molecular Cancer Therapeutics (2014)
The spotted gar genome illuminates vertebrate evolution and facilitates human-teleost comparisons
Ingo Braasch;Andrew R Gehrke;Jeramiah J Smith;Kazuhiko Kawasaki.
Nature Genetics (2016)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre;Kristy G Kuplast;Christina R Majer;P Ann Boriack-Sjodin.
Nature Chemical Biology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: